Logo image
Intravenous thrombolytic therapy for patients with ventricular assist device thrombosis: An attempt to avoid reoperation
Journal article   Open access   Peer reviewed

Intravenous thrombolytic therapy for patients with ventricular assist device thrombosis: An attempt to avoid reoperation

Beth T Webber, Anthony L Panos and Yiliam F Rodriguez-Blanco
Annals of cardiac anaesthesia, Vol.19(1), pp.192-196
2016
DOI: 10.4103/0971-9784.173047
PMCID: PMC4900393
PMID: 26750701
url
https://doi.org/10.4103/0971-9784.173047View
Published (Version of record) Open Access

Abstract

A growing number of patients are undergoing prolonged management of advanced heart failure with the use of continuous flow left ventricular assist devices (LVADs). Subsequently, an increasing number of patients are presenting with complications associated with these devices. Based on an analysis of three major LVAD institutions, the number of patients developing LVAD pump thrombosis may be much higher than originally projected.[ 1 2 ] The management of this highly feared complication continues to be challenging, as the population of LVAD patients is very heterogeneous and heavily burdened with comorbidities. The standard protocol of increasing anticoagulation may fail to achieve successful resolution of thrombus. Difficulty and poor prognosis may make reoperation less than desirable. Here, we present a case of successful thrombolysis following intravenous administration of tissue plasminogen activator in the Intensive Care Unit setting.
Left ventricular assist devices thrombosis Ventricular assist device Case Report Thrombolytic therapy

Details

Metrics

Logo image